Commit Biologics appoints Mikkel Wandahl Pedersen as Chief Scientific Officer
— Highly experienced leader with demonstrated track record of antibody-based drug discovery and pipeline advancement — Strengthens Commit’s leadership team after emerging from stealth with €16m seed financing — Dr Pedersen will spearhead research and development of Commit’s BiCETM technology as the Company moves towards drug candidate (DC) nomination Commit Biologics (“Commit”), a pioneer in […]